REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 19th, 2023 • Celularity Inc • Pharmaceutical preparations
This Registration Rights Agreement (this “Agreement”) is made and entered into as of May 18, 2023, between Celularity Inc., a Delaware corporation (the “Company”), and each of the several Holders signatory hereto.
FORM OF COMMON STOCK PURCHASE WARRANT Celularity Inc.Security Agreement • May 19th, 2023 • Celularity Inc • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [ ] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after May 18, 2023 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on May 18, 2028 (the “Termination Date”), but not thereafter, to subscribe for and purchase from Celularity Inc., a Delaware corporation (the “Company”), up to [ ] shares of Class A common stock, par value $0.0001 per share (the “Common Stock”) (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 19th, 2023 • Celularity Inc • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of May 17, 2023, between Celularity Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature page hereto (including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
